Trade Relay Therapeutics, Inc. - RLAY CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.08
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02237 %(-$0.45)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02237%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00015 %($0.00)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: 0.00015%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02237 %
  (-$0.45)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00015 %
  ($0.00)

Key Stats

• Prev. Close: 19.37
• Open: 19.14
• 1-Year Change: 163.64%
• Day's Range: 17.99 - 19.14

Trade Relay Therapeutics, Inc. - RLAY

What is Relay Therapeutics, Inc. (RLAY)?

Relay Therapeutics, Inc. is a biotechnology company focused on the discovery and development of precision medicines for the treatment of cancer and genetic diseases. The company utilizes a unique approach that combines computational and experimental techniques to understand protein motion and its role in disease. By integrating advanced technologies such as machine learning, high-performance computing, and biophysical methods, Relay Therapeutics aims to design novel therapeutics that target dynamic proteins. The company’s research efforts emphasize the importance of protein dynamics in drug discovery, which differentiates its platform from traditional static structure-based methods. Relay Therapeutics collaborates with academic institutions and industry partners to advance its drug candidates through various stages of development. Its pipeline includes programs targeting oncogenic drivers and other disease-relevant proteins. The company operates within the broader biotechnology sector, contributing to the development of innovative therapies that address unmet medical needs through a mechanistic understanding of protein behavior.

Relay Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by trading momentum, with Relay Therapeutics, Inc. at $18.37. It has moved between $17.93 and $19.2 today, reflecting a daily percentage change of -5.9156%.

FAQ: Relay Therapeutics, Inc. (RLAY)

What is the current price of RLAY stock?

Relay Therapeutics, Inc. shares are priced at $18.37.

Does RLAY pay dividends?

Relay Therapeutics, Inc. does not pay dividends.

Does RLAY have a formal corporate presence or regional headquarters in the UAE?

Relay Therapeutics, Inc. does not maintain an official regional office or subsidiary in the UAE and operates via partners and distributors.

What is RLAY best known for?

The company is most famous for its precision medicine and drug discovery platform.

What assets are typically shown together with RLAY?

Commonly shown alongside RLAY: Tabcorp Holdings, Southwest Gas Holdings Inc, Beach Energy Ltd